Výsledky vyhledávání

TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial

Autor: Deepa Joshi, Prashant GJ, Shohini Ghosh, Anookh Mohanan, Shashank Joshi, Viswanathan Mohan, Subhankar Chowdhury, Chaitanya Dutt, Nikhil Tandon

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 15:615-631

Deepa Joshi,1 Prashant GJ,1 Shohini Ghosh,1 Anookh Mohanan,1 Shashank Joshi,2 Viswanathan Mohan,3 Subhankar Chowdhury,4 Chaitanya Dutt,1 Nikhil Tandon5 1Torrent Pharmaceuticals Ltd., Ahmedabad, Gujarat, India; 2Lilavati Hospital, Mumbai, India; 3Dr.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b425577e2dd3a3924dc42401f4483d74
https://doi.org/10.2147/dmso.s330515

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání